Circulating cell-free DNA (cfDNA) in the blood of cancer patients contains tumor-specific
mutated genes and viral genome that can be identified and quantified as 'tumor-specific …

Immunotherapy for head and neck cancer: from recurrent/metas... : Current Opinion in
Otolaryngology & Head and Neck Surgery Immunotherapy for head and neck cancer: from …

Introduction: Head and neck squamous cell carcinoma (HNSCC) is one of the most common
cancers worldwide and is a leading cause for cancer-related mortality. This review attempts …

The utility of radiotherapy as a means of palliating symptoms due to metastatic cancer is well-
accepted. A growing body of literature suggests that radiotherapy may play a role beyond …

Immunotherapy represents an effective therapeutic option in the management of
recurrent/metastatic head and neck squamous cell carcinoma, along with chemotherapy in …

Histopathology and clinical staging have historically formed the backbone for allocation of
treatment decisions in oncology. Although this has provided an extremely practical and …

Aims The aim of this systematic literature review was to provide updated information on
human papillomavirus (HPV) prevalence in locally and regionally advanced (LA) and …

Introduction We report long-term efficacy and overall survival (OS) results from a
randomised, double-blind, phase 2 study (NCT02022098) investigating xevinapant plus …

Chemo-radiotherapy is the standard treatment for locally advanced head–neck cancer (LA-
HNC). However, about 30% of tumors do not respond or even progress shortly after the …

Head and neck squamous cell carcinomas (HNSCCs) are the seventh most common
malignancy worldwide. HNSCCs are highly heterogeneous diseases with varied genetic …